← Back to All US Stocks

BME Stock Analysis - BlackRock Health Sciences Trust AI Rating

BME NYSE DE CIK: 0001314966
Recently Updated • Analysis: Mar 21, 2026 • SEC Data: 2026-03-21
AI Rating
HOLD
15% Confidence

📊 BME Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: HOLD with 15% confidence

Investment Thesis

BlackRock Health Sciences Trust (BME) is a closed-end fund with insufficient fundamental data available for meaningful analysis. With only 1 metric available and no income statement, balance sheet, or cash flow data provided, a comprehensive assessment of financial health and performance is not possible.

BME Strengths

  • + Listed on NYSE indicating established market presence
  • + Recent insider activity (2 Form 4 filings in last 90 days) suggesting management engagement
  • + BlackRock sponsorship provides institutional backing and professional management

BME Risks

  • ! Severe data quality issues with 99% of fundamental metrics unavailable
  • ! No profitability, liquidity, or solvency metrics to assess financial health
  • ! Inability to evaluate portfolio performance, distributions, or fund stability without financial statements

Key Metrics to Watch

BME Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

BME Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

BME vs Default Sector

How BlackRock Health Sciences Trust compares to Default sector averages

Net Margin
BME 0.0%
vs
Sector Avg 12.0%
BME Sector
ROE
BME 0.0%
vs
Sector Avg 15.0%
BME Sector
Current Ratio
BME 0.0x
vs
Sector Avg 1.8x
BME Sector
Debt/Equity
BME 0.0x
vs
Sector Avg 0.7x
BME Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

BME Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

BME Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

BME SEC Filings

Access official SEC EDGAR filings for BlackRock Health Sciences Trust (CIK: 0001314966)

📋 Recent SEC Filings

Date Form Document Action
Feb 3, 2026 4 xslF345X05/ownership.xml View →
Feb 3, 2026 4 xslF345X05/ownership.xml View →
May 22, 2025 DEF 14A d892899ddef14a.htm View →
Feb 4, 2025 4 xslF345X05/ownership.xml View →
Feb 4, 2025 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about BME

What is the AI rating for BME?

BlackRock Health Sciences Trust (BME) has an AI rating of HOLD with 15% confidence, based on fundamental analysis of SEC EDGAR filings.

What are BME's key strengths?

Listed on NYSE indicating established market presence. Recent insider activity (2 Form 4 filings in last 90 days) suggesting management engagement.

What are the risks of investing in BME?

Severe data quality issues with 99% of fundamental metrics unavailable. No profitability, liquidity, or solvency metrics to assess financial health.

What is BME's revenue and growth?

BlackRock Health Sciences Trust reported revenue of N/A.

Does BME pay dividends?

BlackRock Health Sciences Trust does not currently pay dividends.

Where can I find BME SEC filings?

Official SEC filings for BlackRock Health Sciences Trust (CIK: 0001314966) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is BME's EPS?

BlackRock Health Sciences Trust has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 21, 2026 | Data as of: 2026-03-21 | Powered by Claude AI